Anuh Pharma (506260) Q4 97/98 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 97/98 earnings summary
23 Oct, 2026Executive summary
FY1997-98 profit after tax rose to ₹129.86 lakh from ₹119.69 lakh; sales and operating income declined, while cost control supported profitability.
Proposed dividend of ₹5 per share (50%) and a 1:1 bonus issue funded by ₹34.8 lakh from general reserves.
Financial highlights
Audited sales and operating income ₹166.27 million vs ₹228.95 million; total income ₹169.36 million vs ₹229.36 million.
Profit before tax ₹159.86 lakh vs ₹149.69 lakh; tax provision ₹30 lakh in both years; net profit ₹129.86 lakh vs ₹119.69 lakh.
Other income increased to ₹3.09 million from ₹0.41 million, including net interest income of ₹2.63 million.
Materials, stores and tools consumed ₹139.83 million vs ₹189.91 million; depreciation rose to ₹1.06 million from ₹0.70 million.
Outlook and guidance
Export sales promotion planned to drive a sizeable increase in export turnover; directors expected satisfactory current-year turnover and profits, barring unforeseen circumstances.
Latest events from Anuh Pharma
- Sales and exports grew as the new Tarapur API facility came on stream.506260
Q4 06/07 - Profit rose despite falling sales, with export growth and deposit-compliance concerns.506260Q4 98/99
- Sales rose 50% and exports climbed to Rs 99.03m as PAT reached Rs 24.34m.506260Q4 99/00
- PAT rose to ₹39.80m as exports grew and Tarapur capacity expansion began.506260Q4 01/02
- Sales grew 11.6%, exports surged, and PAT softened; dividend rose to ₹12.50/share.506260Q4 02/03
- Sales rose 50.1%, exports 46.5%, and PAT reached Rs 60.3m in FY04.506260Q4 03/04
- Profit fell amid export weakness; a new factory targets ~70% more capacity.506260Q4 04/05
- Sales rose 49.14%, PAT grew 41.57%, and the new factory came on stream.506260Q4 05/06
- FY08 sales rose 35%, PAT grew 13.29%, and 150 MT of capacity was planned.506260Q4 07/08